Successful Treatment of Crizotinib-Induced Fulminant Liver Failure: A Case Report and Review of Literature

Crizotinib is a first-line tyrosine kinase inhibitor used for the treatment of metastatic lung cancer. Crizotinib-induced hepatotoxicity is a rare event. We report a case of a 46-year-old female with a history of metastatic lung cancer who presented with acute liver failure after being on crizotinib...

Full description

Saved in:
Bibliographic Details
Main Authors: Kyle Kreitman, Satheesh P. Nair, Jiten P. Kothadia
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Case Reports in Hepatology
Online Access:http://dx.doi.org/10.1155/2020/8247960
Tags: Add Tag
No Tags, Be the first to tag this record!